Search in:

Advanced search

Acta Cardiologica Volume 76, 2021 - Issue 9

Submit an article Journal homepage

305

Views

CrossRef citations to date

Altmetric

Review Articles

A network meta-analysis of non-vitamin K antagonist oral anticoagulants versus warfarin in patients with atrial fibrillation and diabetes mellitus

Hao Jina School of Medicine, Southeast University, Nanjing, China

Kongbo Zhub Department of Cardiology, Affiliated ZhongDa Hospital of Southeast University (HZ), Nanjing, China

Lina Wangc Department of Epidemiology and Biostatistics, School of Public Health, Southeast University, Nanjing, China

Hong Zhib Department of Cardiology, Affiliated ZhongDa Hospital of Southeast University (HZ), Nanjing, ChinaCorrespondence[email protected]

Pages 960-969 | Received 10 Nov 2020, Accepted 22 Dec 2020, Published online: 12 Jan 2021

Cite this article
https://doi.org/10.1080/00015385.2020.1869671
CrossMark

Full Article
Figures & data
References
Supplemental
Citations
Metrics
Reprints & Permissions

References

Lane DA, Skjøth F, Lip GYH, et al. Temporal trends in incidence, prevalence, and mortality of atrial fibrillation in primary care. JAHA. 2017;6(5):e005155.
Google Scholar
Zghebi SS, Steinke DT, Carr MJ, et al. Examining trends in type 2 diabetes incidence, prevalence and mortality in the UK between 2004 and 2014. Diabetes Obes Metab. 2017;19(11):1537–1545.
PubMed Web of Science ®Google Scholar
Pallisgaard JL, Schjerning AM, Lindhardt TB, et al. Risk of atrial fibrillation in diabetes mellitus: a nationwide cohort study. Eur J Prev Cardiol. 2016;23(6):621–627.
PubMed Web of Science ®Google Scholar
Plitt A, McGuire DK, Giugliano RP. Atrial fibrillation, type 2 diabetes, and non-vitamin K antagonist oral anticoagulants: a review. JAMA Cardiol. 2017;2(4):442–448.
PubMed Web of Science ®Google Scholar
Santos JV, Pereira J, Pinto R, et al. Atrial fibrillation as an ischemic stroke clinical and economic burden modifier: a 15-year nationwide study. Value Health. 2017;20(8):1083–1091.
Web of Science ®Google Scholar
January CT, Wann LS, Calkins H, et al. 2019 AHA/ACC/HRS focused update of the 2014 AHA/ACC/HRS guideline for the management of patients with atrial fibrillation: a report of the American College of Cardiology/American Heart Association task force on clinical practice guidelines and the heart rhythm society in collaboration with the society of thoracic surgeons. Circulation. 2019;140(2):e125–e151.
PubMed Web of Science ®Google Scholar
Patti G, Gioia GD, Cavallari I, et al. Safety and efficacy of nonvitamin K antagonist oral anticoagulants versus warfarin in diabetic patients with atrial fibrillation: a study-level meta-analysis of phase III randomized trials. Diabetes Metab Res Rev. 2017;33(3):e2876.
Web of Science ®Google Scholar
Spiegelhalter DJ, Best NG, Carlin BP, et al. Bayesian measures of model complexity and fit. J Royal Statistical Soc B. 2002;64(4):583–639.
Google Scholar
Turner RM, Davey J, Clarke MJ, et al. Predicting the extent of heterogeneity in meta-analysis, using empirical data from the Cochrane Database of Systematic Reviews. Int J Epidemiol. 2012;41(3):818–827.
PubMed Web of Science ®Google Scholar
Brooks SP, Gelman A. General methods for monitoring convergence of iterative simulations. J Comput Graph Stat. 1998;7(4):434–455.
Web of Science ®Google Scholar
Brambatti M, Darius H, Oldgren J, et al. Comparison of dabigatran versus warfarin in diabetic patients with atrial fibrillation: results from the RE-LY trial. Int J Cardiol. 2015;196:127–131.
PubMed Web of Science ®Google Scholar
Plitt A, Ruff CT, Goudev A, et al. Efficacy and safety of edoxaban in patients with diabetes mellitus in the ENGAGE AF-TIMI 48 trial. Int J Cardiol. 2020;304:185–191.
PubMed Web of Science ®Google Scholar
Ezekowitz JA, Lewis BS, Lopes RD, et al. Clinical outcomes of patients with diabetes and atrial fibrillation treated with apixaban: results from the ARISTOTLE trial. Eur Heart J Cardiovasc Pharmacother. 2015;1(2):86–94.
PubMed Web of Science ®Google Scholar
Bansilal S, Bloomgarden Z, Halperin JL, et al. Efficacy and safety of rivaroxaban in patients with diabetes and nonvalvular atrial fibrillation: the rivaroxaban once-daily, oral, direct factor Xa inhibition compared with vitamin K antagonism for prevention of stroke and embolism trial in atrial fibrillation (ROCKET AF trial). Am Heart J. 2015;170(4):675–682.e8.
PubMed Web of Science ®Google Scholar
Wang A, Green JB, Halperin JL, et al. Atrial fibrillation and diabetes mellitus: JACC review topic of the week. J Am Coll Cardiol. 2019;74(8):1107–1115.
PubMed Web of Science ®Google Scholar
Bell DSH, Goncalves E. Atrial fibrillation and type 2 diabetes: prevalence, etiology, pathophysiology and effect of anti-diabetic therapies. Diabetes Obes Metab. 2019;21(2):210–217.
PubMed Web of Science ®Google Scholar
Overvad TF, Skjøth F, Lip GY, et al. Duration of diabetes mellitus and risk of thromboembolism and bleeding in atrial fibrillation: nationwide cohort study. Stroke. 2015;46(8):2168–2174.
PubMed Web of Science ®Google Scholar
Johnsen SP, Dalby LW, Täckström T, et al. Cost of illness of atrial fibrillation: a nationwide study of societal impact. BMC Health Serv Res. 2017;17(1):714.
PubMed Web of Science ®Google Scholar
Itzhaki Ben Zadok O, Eisen A. Use of non-vitamin K oral anticoagulants in people with atrial fibrillation and diabetes mellitus. Diabet Med. 2018;35(5):548–556.
Web of Science ®Google Scholar
Lip GYH, Keshishian AV, Kang AL, et al. Effectiveness and safety of oral anticoagulants in patients with nonvalvular atrial fibrillation and diabetes mellitus. Mayo Clin Proc. 2020;95(5):929–943.
PubMed Web of Science ®Google Scholar
Acar T, Aras YG, Gül SS, et al. Effective INR level may be delayed in secondary prevention of stroke due to atrial fibrillation with warfarin in the patients with diabetes mellitus. Noro Psikiyatri Arsivi. 2019;56(4):273–276.
Google Scholar
Terry CM, He Y, Cheung AK. Rivaroxaban improves patency and decreases inflammation in a mouse model of catheter thrombosis. Thromb Res. 2016;144:106–112.
PubMed Web of Science ®Google Scholar
Feldmann K, Grandoch M, Kohlmorgen C, et al. Decreased M1 macrophage polarization in dabigatran-treated Ldlr-deficient mice: implications for atherosclerosis and adipose tissue inflammation. Atherosclerosis. 2019;287:81–88.
Web of Science ®Google Scholar
Samoš M, Bolek T, Stančiaková L, et al. Does type 2 diabetes affect the on-treatment levels of direct oral anticoagulants in patients with atrial fibrillation? Diabetes Res Clin Pract. 2018;135:172–177.
Web of Science ®Google Scholar
Olesen JB, Lip GY, Kamper AL, et al. Stroke and bleeding in atrial fibrillation with chronic kidney disease. N Engl J Med. 2012;367(7):625–635.
PubMed Web of Science ®Google Scholar
HernandezAV, Bradley G, Khan M, et al. Rivaroxaban versus warfarin and renal outcomes in non-valvular atrial fibrillation patients with diabetes, European heart journal. Qual Care Clin Outcom. 2019;6(4).
Google Scholar

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Share icon
Back to Top

A bold vision to stop cardiovascular disease from being a leading cause of death.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.

People also read
Recommended articles
Cited by

To cite this article:

Reference style: APA Chicago Harvard

Citation copied to clipboard

Reference styles above use APA (6th edition), Chicago (16th edition) & Harvard (10th edition)

Download citation

Download a citation file in RIS format that can be imported by citation management software including EndNote, ProCite, RefWorks and Reference Manager.

Choose format: RIS BibTex RefWorks Direct Export

Choose options: Citation Citation & abstract Citation & references

A network meta-analysis of non-vitamin K antagonist oral anticoagulants versus warfarin in patients with atrial fibrillation and diabetes mellitus

References

Information for

Open access

Opportunities

Help and information

Your download is now in progress and you may close this window

Login or register to access this feature

A network meta-analysis of non-vitamin K antagonist oral anticoagulants versus warfarin in patients with atrial fibrillation and diabetes mellitus

References

Reprints and Corporate Permissions

Academic Permissions

Related research

To cite this article:

Download citation

Information for

Open access

Opportunities

Help and information

Keep up to date